SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rudy Saucillo who wrote (2197)5/26/1999 7:09:00 PM
From: John Metcalf  Read Replies (3) of 2742
 
Good point, Rudy. ONLY the future is important.

The fact that the Board has not appointed an operating officer may suggest that they intend to liquidate, rather than operate the company. Perhaps Pasteur will pay cash for Ciston's interest in the vaccine adjuvant program, or perhaps issue contingent warrants to shareholders, as Skye did for Depotech holders. It is also possible to sell other interests in IL1B, particularly in cancer treatment, as Rick used to point out.

For this, they only need a Board and CEO, which is what they have.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News